Edition:
United Kingdom

Granules India Ltd (GRAN.NS)

GRAN.NS on National Stock Exchange of India

138.95INR
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs138.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,478,287
52-wk High
Rs157.25
52-wk Low
Rs101.25

Latest Key Developments (Source: Significant Developments)

Granules India's Virginia Unit Completes U.S. FDA Audit With 1 Observation
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Granules India Ltd ::SAYS GRANULES PHARMACEUTICALS COMPLETES U.S. FDA INSPECTION WITH 1 OBSERVATION.  Full Article

Granules India Sept-qtr consol profit falls
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Granules India Ltd :Sept quarter consol net profit 403.4 million rupees versus profit 408.2 million rupees year ago.Sept quarter consol revenue from operations 3.93 billion rupees versus 3.64 billion rupees year ago.Declared dividend of 0.25 rupees per share.  Full Article

Granules India gets US FDA nod for Ibuprofen 200 mg tablets
Thursday, 13 Oct 2016 

Granules India Ltd :Granules India says Granules India Limited, received US FDA approval for Ibuprofen 200 mg tablets.  Full Article

Granules India unit to buy 12.5 pct stake in USpharma
Thursday, 14 Jul 2016 

Granules India Ltd : Unit in agreeement with USpharma to acquire 12.5% stake; co will get right of first refusal to market select products .  Full Article

Granules India's Jeedimetla plant gets EIR from US FDA
Monday, 30 May 2016 

Granules India Ltd : Granules India's Jeedimetla plant received Establishment Inspection Report from the US FDA .  Full Article

BRIEF-RBI Hikes Foreign Investment Limit In Granules India To 49 Pct

* RBI - INCREASE IN FPIS INVESTMENT LIMIT IN GRANULES INDIA FROM 24 PERCENT TO 49 PERCENT Source text: http://bit.ly/2Fuk1c9 Further company coverage: